Inhaled Combined Budesonide–Formoterol as Needed in Mild Asthma
The New England Journal of Medicine, pp. 1865-1876, 2018.
Abstract Background In patients with mild asthma, as-needed use of an inhaled glucocorticoid plus a fast-acting β2-agonist may be an alternative to conventional treatment strategies. Methods We conducted a 52-week, double-blind trial involving patients 12 years of age or older with mild asthma. Patients were randomly assigned to one of th...More